CLARITY LAB SOLUTIONS LLC NPI 1033655303

NPI Details

CLARITY LAB SOLUTIONS, LLC is a clinical medical laboratory in Deerfield Beach, FL. The provider is (1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology. CLARITY LAB SOLUTIONS, LLC NPI is 1033655303. The provider is registered as an organization entity type.

The provider's business location address is:

1701 GREEN RD STE A
DEERFIELD BEACH, FL
ZIP 33064-074
Phone: (800) 864-9204
Fax: (954) 329-2196

The provider's authorized official is Yosef M Grossman .
The authorized official title is Owner and has the following contact phone number (800) 864-9204.

The CLIA number assigned to this NPI record is 10D2119017 - independent with a certificate type of Certificate of Accreditation.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Detection test by nucleic acid for organism, amplified probe technique (HCPCS:87798)
• Detection test by nucleic acid for multiple organisms, amplified probe(s) technique (HCPCS:87801)
• 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0004)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
• Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique (HCPCS:87640)
• Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution (HCPCS:87186)
• Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique (HCPCS:87651)
• Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique (HCPCS:87500)
• Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique (HCPCS:87653)
• Detection test for candida species (yeast), amplified probe technique (HCPCS:87481)
• Detection test by nucleic acid for organism, quantification (HCPCS:87799)
• Detection of mycoplasma genitalium by dna or rna probe (HCPCS:87563)
• Detection test for candida species (yeast), quantification (HCPCS:87482)
• Detection test by nucleic acid for chlamydia pneumoniae, amplified probe technique (HCPCS:87486)
• Detection test by nucleic acid for mycoplasma pneumoniae (bacteria), amplified probe technique (HCPCS:87581)
• Detection test by nucleic acid for multiple types influenza virus (HCPCS:87502)
• Detection test by nucleic acid for legionella pneumophila (water borne bacteria), amplified probe technique (HCPCS:87541)
• Detection test by nucleic acid for respiratory syncytial virus, amplified probe technique (HCPCS:87634)
• Detection test by nucleic acid for cytomegalovirus (cmv), amplified probe technique (HCPCS:87496)
• Detection test by nucleic acid for herpes virus-6, amplified probe technique (HCPCS:87532)
• Detection test by nucleic acid for enterovirus (intestinal virus), amplified probe technique (HCPCS:87498)
• Detection test by nucleic acid for mycobacteria species (bacteria), amplified probe technique (HCPCS:87551)
• Detection by nucleic acid bartonella henselae and bartonella quintana (bacteria), amplified probe technique (HCPCS:87471)
• Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique (HCPCS:87641)
• Automated urinalysis test (HCPCS:81003)
• Detection test by nucleic acid for multiple types influenza virus, each additional influenza virus type or sub-type (HCPCS:87503)
• Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen (HCPCS:87635)
• Detection test by nucleic acid for multiple types of respiratory virus, multiple types or subtypes, 3-5 targets (HCPCS:87631)
• Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus (HCPCS:87637)
• Urine microalbumin (protein) analysis (HCPCS:82044)
• Creatinine level to test for kidney function or muscle injury (HCPCS:82570)

The enumeration date for this NPI number is 1/11/2017 and was last updated on 4/25/2025.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: